Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13743010 | 0.94 | ALDH1A1 (0.68) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL12794350 | 0.94 | ALDH1A1 (0.68) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL12794352 | 0.94 | ALDH1A1 (0.68) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL12794355 | 0.88 | ALDH1A1 (0.60) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL3397898 | 0.78 | USP2 (0.68) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL6522833 | 0.78 | USP2 (0.68) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL20924903 | 0.76 | ALDH1A1 (0.48) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL12847942 | 0.73 | DNM1 (0.55) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL12847938 | 0.73 | DNM1 (0.55) | ALDH1A1USP2ALOX15TDP1DNM1 | |
| SCHEMBL3400533 | 0.72 | ALDH1A1 (0.60) | ALDH1A1USP2ALOX15TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L' OREAL (FR) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | SGMS2, SGMS1, CATSPER1 | ALDH1A1 2384/4885USP2 4456/4885ALOX15 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.